Drug May Improve Outcomes for CNS Lymphomas - Study finds cytarabine addition to methotrexate improves remission rates - ModernMedicine
Links shared publicly online about this topic.
- 1,731total visits
Drug May Improve Outcomes for CNS Lymphomas - Study finds cytarabine addition to methotrexate improves remission rates - ModernMedicine
The addition of high-dose cytarabine to standard methotrexate treatment of primary central nervous system lymphomas greatly improves remission rates, according to a study published early online Sept. 20 in The Lancet to coincide with the European Cancer Organisation meeting in Berlin.
View full resource at modernmedicine.com
Tags: Nervous System, Cancer, Lymphoma, Rheumatoid Arthritis Medication, Drug, Rheumatrex, Trexall, Folex PFS
Most Recently Shared on September 22, 2009 at 1:38 am By:
Study shows high-dose Cytarabine to standard treatment greatly improves CNS Lymphoma remission rates. http://bit.ly/wN0O9
Advertisement
